SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-346236
Filing Date
2012-08-09
Accepted
2012-08-09 11:30:12
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d354946d10q.htm 10-Q 756250
2 SECTION 302 CEO CERTIFICATION d354946dex311.htm EX-31.1 10024
3 SECTION 302 CFO CERTIFICATION d354946dex312.htm EX-31.2 10045
4 SECTION 906 CEO CERTIFICATION d354946dex321.htm EX-32.1 4281
5 SECTION 906 CFO CERTIFICATION d354946dex322.htm EX-32.2 4302
  Complete submission text file 0001193125-12-346236.txt   4280793

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aegr-20120630.xml EX-101.INS 613522
7 XBRL TAXONOMY EXTENSION SCHEMA aegr-20120630.xsd EX-101.SCH 42180
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20120630_cal.xml EX-101.CAL 59673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20120630_def.xml EX-101.DEF 207304
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20120630_lab.xml EX-101.LAB 302230
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20120630_pre.xml EX-101.PRE 247272
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 121019161
SIC: 2834 Pharmaceutical Preparations